Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 9580 matches for

A team of international researchers, including scientists at the MRC Molecular Haematology Unit, report promising results from a phase I clinical trial of Enasidenib, a novel drug that may help patients suffering from Acute Myeloid Leukaemia.

None © Martin Phelps

Antanaviciute Group (iCase): The GI Chronicle project: Exploring the effect of age on intestinal epithelial & immune function

Bannard Group: Development of Antibody-Mediated Immunity following Infection and Vaccination (B Cell Immunology)

Chakraverty Group: Identifying novel CD4+ T cell platforms for immunotherapy

Antanaviciute Group: Decrypting human intestinal development

Ogg Group: Discovery of new approaches to treat skin inflammation

Sharma Group: Comparative Analysis of TCR-Mediated Cytotoxicity Using Genome-Wide CRISPR Screens to Identify Host Factors in Natural vs. Vaccine-Induced Immunity

Simmons Group: Engineering Intestinal Mesenchymal Niches to Promote Epithelial Barrier Health Through Life

Nerlov Group: Single Cell Biology and Machine Learning in Blood Development, Cancer and Ageing

Twigg Group: Pathogenic mechanisms in craniofacial malformations

Vyas Group: Genetic And Epigenetic Mechanisms Leading To Acute Myeloid Leukaemia. Developing New Targeted Therapeutic Approaches

Koohy Group: Decoding the underlying rules of T cell response by AI and Machine-Learning strategies

Koohy Group: Decoding the underlying rules of T cell response by AI and Machine-Learning strategies

Chakraverty Group: Identifying novel CD4+ T cell platforms for immunotherapy

Ogg Group: Discovery of new approaches to treat skin inflammation

Sharma Group: Comparative Analysis of TCR-Mediated Cytotoxicity Using Genome-Wide CRISPR Screens to Identify Host Factors in Natural vs. Vaccine-Induced Immunity

Simmons Group: Engineering Intestinal Mesenchymal Niches to Promote Epithelial Barrier Health Through Life

Antanaviciute Group: Decrypting human intestinal development

MRC WIMM lab projects managed through other Oxford DPhil programmes

The MRC WIMM hosts research groups from various departments in the Medical Sciences Division, in addition to those from the Radcliffe Department of Medicine. Projects advertised here are offered by WIMM supervisors through DPhil programmes other than the RDM DPhil in Medical Sciences.

Kassouf Group: Understanding the principles of gene expression in health and disease

Kassouf Group: Understanding the principles of gene expression in health and disease

Load More

Tell us your news

Paper accepted?

Received an award?

Contact communications@imm.ox.ac.uk to feature your story.

Similar stories